144 related articles for article (PubMed ID: 23030285)
1. Long-term clinical experience with zofenopril.
Borghi C; Bacchelli S; Degli Esposti D
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):973-82. PubMed ID: 23030285
[TBL] [Abstract][Full Text] [Related]
2. Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
Borghi C; Ambrosioni E; Omboni S; Cicero AF; Bacchelli S; Esposti DD; Vinereanu D; Ambrosio G; Zava D;
J Hypertens; 2013 Jun; 31(6):1256-64. PubMed ID: 23552127
[TBL] [Abstract][Full Text] [Related]
3. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
Borghi C; Ambrosioni E; Novo S; Vinereanu D; Ambrosio G;
Clin Cardiol; 2012; 35(7):416-23. PubMed ID: 22707187
[TBL] [Abstract][Full Text] [Related]
4. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Borghi C; Ambrosioni E;
Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
[TBL] [Abstract][Full Text] [Related]
5. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
6. [Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
Abuladze GV; Nebieridze MI; Narsiia EV; Erkomaishvili IG; Pipiia NG
Georgian Med News; 2011 Jun; (195):37-40. PubMed ID: 21778538
[TBL] [Abstract][Full Text] [Related]
7. Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients.
Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E;
Cardiovasc Ther; 2016 Apr; 34(2):76-84. PubMed ID: 26789425
[TBL] [Abstract][Full Text] [Related]
8. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
9. A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E
Expert Opin Pharmacother; 2004 Sep; 5(9):1965-77. PubMed ID: 15330734
[TBL] [Abstract][Full Text] [Related]
10. [ACE inhibitors after myocardial infarction: close-up on zofenopril].
Teyssedou A
Ann Cardiol Angeiol (Paris); 2007 Jun; 56(3):137-44. PubMed ID: 17482555
[TBL] [Abstract][Full Text] [Related]
11. Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study.
Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E
J Cardiovasc Pharmacol; 2017 May; 69(5):298-304. PubMed ID: 28195948
[TBL] [Abstract][Full Text] [Related]
12. Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
Buikema H
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):631-47. PubMed ID: 17081085
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
Borghi C; Omboni S; Reggiardo G; Bacchelli S; Degli Esposti D; Ambrosioni E;
Blood Press; 2017 Aug; 26(4):211-219. PubMed ID: 28155333
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
Lombardi C; Castrini AI; Metra M; Carubelli V; Lazzarini V; Inama L; Dei Cas L
G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):55S-58S. PubMed ID: 23096377
[TBL] [Abstract][Full Text] [Related]
15. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.
Borghi C; Cicero AF
Vasc Health Risk Manag; 2006; 2(4):341-9. PubMed ID: 17323587
[TBL] [Abstract][Full Text] [Related]
16. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
Ambrosioni E; Borghi C; Magnani B
Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
[TBL] [Abstract][Full Text] [Related]
17. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies.
Borghi C; Omboni S; Reggiardo G; Bacchelli S; Esposti DD; Ambrosioni E;
BMC Cardiovasc Disord; 2018 Jun; 18(1):112. PubMed ID: 29866077
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
Borghi C; Omboni S; Novo S; Vinereanu D; Ambrosio G; Ambrosioni E
Adv Ther; 2018 May; 35(5):604-618. PubMed ID: 29667144
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
Franconi F; Omboni S; Ambrosioni E; Reggiardo G; Campesi I; Borghi C
PLoS One; 2014; 9(11):e111558. PubMed ID: 25364906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
